Strongbridge Biopharma Plc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2021 to a ratio of 11.46, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the second quarter 2021. Average collection period, for Strongbridge Biopharma Plc's accounts receivable remained unchanged at 32 days, in the Jun 30 2021 quarter.

If we take a look into Healthcare sector 335 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2021 from 1052 to 2489.

What is Receivable Turnover Ratio?
What is Strongbridge Biopharma Plc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SBBP Receivables Turnover Ratio	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter
Y / Y Receivable Change	24.12 %	5.8 %	22.37 %	-13.89 %	-54.52 %
Y / Y Revenue Change	29.41 %	25.59 %	46.74 %	42 %	27.65 %
Receivable Turnover Ratio (TTM)	11.46	11.36	10.91	10.45	9.17
SBBP's Total Ranking	# 2489	# 1052	# 2488	# 2488	# 1199
Accounts Receivable average collection period days	32	32	33	35	40
Seq. Receivable Change	25.83 %	1.61 %	-3.25 %	0.35 %	7.25 %
Seq. Revenue Change	19.8 %	1.9 %	1.92 %	4.01 %	16.27 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 97
Healthcare Sector	# 336
Overall Market	# 2489

Receivable Turnover Ratio Statistics
High	Average	Low
0.31	0.18	0.09
(Jun 30 2021)		(Mar 31 2018)

SBBP Company Profile • Back to SBBP Efficiency Comparisons • Compare SBBP Receivables Turnover Ratio to its Competitors

Financial Statements
Strongbridge Biopharma Plc's Accounts Receivable	$ 4 Millions	Visit SBBP's Balance sheet
Strongbridge Biopharma Plc's Sales TTM	$ 35 Millions	Visit SBBP's Income Statement
Sources of SBBP's Revenues		Visit SBBP's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SBBP's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SBBP's Growth Rates	SBBP's Roa	SBBP's Inventory Turnover Ratio	SBBP's Dividend Comparisons
SBBP's Profitability Ratios	SBBP's Roi	SBBP's Asset Turnover Ratio	SBBP's Dividend Growth
SBBP's Valuation Ratios	SBBP's Roe	SBBP's Financial Strength Ratios	SBBP's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2021, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2021	Receivable at quarter ending Jun 30 2021
Intellia Therapeutics Inc	26.58	$ 41.810 Millions	$ 1.573 Millions
Molecular Templates Inc	25.99	$ 26.149 Millions	$ 1.006 Millions
G1 Therapeutics Inc	24.97	$ 63.967 Millions	$ 2.562 Millions
Endonovo Therapeutics Inc	24.87	$ 0.116 Millions	$ 0.005 Millions
Delcath Systems Inc	24.48	$ 1.897 Millions	$ 0.078 Millions
Ensysce Biosciences Inc	23.60	$ 0.445 Millions	$ 0.019 Millions
Ideaya Biosciences Inc	23.21	$ 35.541 Millions	$ 1.531 Millions
Butterfly Network Inc	23.15	$ 83.270 Millions	$ 3.597 Millions
Ethema Health Corporation	22.42	$ 0.360 Millions	$ 0.016 Millions
Grapefruit Usa Inc	22.06	$ 2.831 Millions	$ 0.128 Millions
China Pharma Holdings Inc	22.04	$ 10.106 Millions	$ 0.458 Millions
Agape Atp Corporation	21.72	$ 2.534 Millions	$ 0.117 Millions
Todos Medical Ltd	21.60	$ 11.938 Millions	$ 0.553 Millions
Catalyst Pharmaceuticals Inc	21.37	$ 126.902 Millions	$ 5.938 Millions
Harrow Inc	21.17	$ 62.571 Millions	$ 2.955 Millions
Reflect Scientific Inc	20.15	$ 3.559 Millions	$ 0.177 Millions
Innovage Holding Corp	19.53	$ 637.801 Millions	$ 32.661 Millions
Talkspace Inc	19.00	$ 31.433 Millions	$ 1.654 Millions
Revance Therapeutics Inc	18.39	$ 47.071 Millions	$ 2.560 Millions
Cv Sciences Inc	18.38	$ 20.735 Millions	$ 1.128 Millions
Chemed Corporation	18.22	$ 2,121.202 Millions	$ 116.442 Millions
Petvivo Holdings Inc	18.11	$ 0.015 Millions	$ 0.001 Millions
Dariohealth Corp	17.69	$ 11.360 Millions	$ 0.642 Millions
Cormedix Inc	17.43	$ 0.245 Millions	$ 0.014 Millions
Rafael Holdings Inc	17.34	$ 3.971 Millions	$ 0.229 Millions
Neurometrix Inc	17.27	$ 8.215 Millions	$ 0.476 Millions
Inhibrx Biosciences Inc	17.08	$ 10.520 Millions	$ 0.616 Millions
Electrocore Inc	16.68	$ 4.482 Millions	$ 0.269 Millions
Cytomx Therapeutics Inc	16.51	$ 66.420 Millions	$ 4.022 Millions
Scorpius Holdings inc	16.47	$ 2.451 Millions	$ 0.149 Millions

Date modified: 2026-08-31T17:15:22+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.